Alb-Interferon Alfa 2b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alb-Interferon Alfa 2b, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals [Phase 1]